- Relay Therapeutics (NASDAQ:RLAY) on Monday said it has commenced an underwritten public offering of $200 million of shares of its common stock.
- Relay Therapeutics also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering.
- RLAY -6.41% after hours to $8.9.
- Source: Press Release
